Six months ago.
Proteomics International rescinds PromarkerD exclusive licence deal with PrismHealthDx in US – negotiations brought forward with new tier 1 partners.
Two months ago.
Proteomics International to use the BIO opportunity to meet with partners for their US roll-out as part of their global expansion of PromarkerD, which now includes Mexico and the EU.
Today
Proteomics International encouraged by interest from a range of global companies and tier 1 national diagnostic groups.
They have dropped any talk of tier 1 partners in the 4c. and now simply refer to them as tier 1 international groups.
Like Eqz, I look forward to the significant updates from Richard in the coming weeks, and significant they need to be.
Ann: Appendix 4C - June 2019 Quarterly Report, page-13
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
-0.015(1.41%) |
Mkt cap ! $137.4M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.06 | $1.02 | $136.4K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 443 | 1 |
View Market Depth
| Last trade - 15.52pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.05 |
Change
-0.015 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| $1.05 | $1.06 | $1.03 | 34377 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| PIQ (ASX) Chart |